Welcome to our dedicated page for Camber Energy SEC filings (Ticker: CEI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wildfire-mitigation patents, carbon-capture licensing, and multiple subsidiaries make Camber Energy’s SEC disclosures anything but straightforward. If you’ve asked, “How do I find Camber Energy’s quarterly earnings report 10-Q filing?” or “Where are Camber Energy insider trading Form 4 transactions listed?” you already know the challenge: valuable data is scattered across dense reports.
Stock Titan solves that problem. Our AI-powered summaries translate the technical language inside each 10-K and 10-Q into plain English, tagging every mention of grid-resiliency revenue, broken-conductor R&D, and carbon-capture milestones. Real-time alerts surface Camber Energy Form 4 insider transactions the moment executives buy or sell shares, while 8-K material events are explained in context so you understand why a new licensing deal matters.
Use the platform to:
- Scan a Camber Energy annual report 10-K simplified for segment revenue tied to Simson-Maxwell and Viking Ozone Technology.
- Compare quarter-over-quarter results with an AI synopsis of each Camber Energy earnings report filing analysis.
- Track Camber Energy executive stock transactions Form 4 and proxy statement executive compensation without digging through exhibits.
Every filing type—10-K, 10-Q, 8-K, S-1, DEF 14A, and more—is indexed and refreshed the instant it hits EDGAR. Whether you’re searching for “Camber Energy SEC filings explained simply” or need “Camber Energy 8-K material events explained,” our expert analysis delivers the clarity professionals require.
Bon Natural Life Limited (BON) – Form 6-K, July 2025
The filing reports that subsidiary Xi’an App-Chem Bio (Tech) Co., Ltd. signed a 24-month Sales Cooperation Agreement with Beijing Huahai Keyuan Technology Co., Ltd. on 10 June 2025. Huahai Keyuan receives a non-exclusive right to market, distribute and sell App-Chem’s natural prebiotic series products throughout China.
Key commercial terms
- Guaranteed sales: Huahai Keyuan commits to purchase at least US$16 million of products over the two-year term.
- Revenue recognition & cash risk: App-Chem must receive full payment in advance before dispatch, materially reducing counter-party credit exposure.
- Operational obligations: App-Chem handles R&D, production, packaging and quality control to ensure compliance with Chinese national standards. If product quality fails, App-Chem bears all associated testing and return costs.
- Termination & penalties: • Either party may terminate by mutual consent.
• Cure period for breach: 30 working days.
• Wrongful termination triggers liquidated damages equal to 15 % of the total contract value.
• Partial non-performance penalty: 10 % of the unperformed portion. - Jurisdiction: Disputes to be litigated in a court located where the Company is registered.
The agreement provides BON with a sizeable minimum revenue pipeline, enhances cash flow security via pre-payment, and expands distribution reach within China. However, the deal is non-exclusive, exposes the company to product-quality liabilities, and the guaranteed figure’s materiality to overall revenues is not disclosed.
Deutsche Bank AG is offering $3.0 million of 5.00% Fixed-Rate Callable Senior Debt Funding Notes maturing on 29 June 2029. The notes are issued at 100% of principal (minimum 99.65% for certain institutional or fee-based accounts) in minimum denominations of $1,000. Interest is paid annually in arrears each 30 June, calculated on a 30/360 basis. The bank may, at its sole discretion and subject to regulatory approval, redeem the notes at par in whole (not in part) on any semi-annual Optional Redemption Date beginning 30 June 2026 and ending 30 December 2028.
The securities are unsecured, unsubordinated senior preferred obligations intended to qualify as eligible liabilities for the EU Minimum Requirement for Own Funds and Eligible Liabilities (MREL). They are not FDIC-insured and carry typical Deutsche Bank credit risk. As bail-in eligible instruments, holders explicitly consent to possible Resolution Measures under EU/ German banking law, including write-down to zero or conversion into equity should the Single Resolution Board deem the bank non-viable.
Key economics
- Issue/Settlement dates: 26 June 2025 / 30 June 2025
- Principal amount: $3,000,000
- Gross proceeds to issuer: $2,994,000 after 0.35% maximum selling concession ($3.50 per note)
- CUSIP/ISIN: 25161FJF6 / US25161FJF62
- No stock-exchange listing; book-entry only via DTC
Primary risks include issuer credit risk, discretionary early redemption, interest-rate reinvestment risk if called, and potential bail-in loss under EU resolution rules. The small size and standard terms make the issuance largely immaterial to Deutsche Bank’s capital structure, but investors should assess whether the 5% fixed coupon adequately compensates for the credit and structural risks.
FAQ
What is the current stock price of Camber Energy (CEI)?
What is the market cap of Camber Energy (CEI)?
What is Camber Energy, Inc.?
How does Camber Energy generate revenue?
What are some of the company’s key technologies?
Who are the primary customers of Camber Energy?
How does Camber Energy address safety and public risk?
What role do its subsidiaries play in the business model?
How is intellectual property important to Camber Energy?
What distinguishes Camber Energy from competitors?
